» Articles » PMID: 36682958

Sex Differences in Dementia with Lewy Bodies: Focused Review of Available Evidence and Future Directions

Overview
Specialty Neurology
Date 2023 Jan 22
PMID 36682958
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, we summarize the current knowledge on sex differences in dementia with Lewy bodies (DLB) relating to epidemiology, clinical features, neuropathology, biomarkers, disease progression, and caregiving. While many studies show a higher DLB prevalence in men, this finding is inconsistent and varies by study approach. Visual hallucinations may be more common and occur earlier in women with DLB, whereas REM sleep behavior disorder may be more common and occur earlier in men. Several studies report a higher frequency of parkinsonism in men with DLB, while the frequency of fluctuations appears similar between sexes. Women tend to be older, have greater cognitive impairment at their initial visit, and are delayed in meeting DLB criteria compared to men. Women are also more likely to have Lewy body disease with co-existing AD-related pathology than so-called "pure" Lewy body disease, while men may present with either. Research is mixed regarding the impact of sex on DLB progression. Biomarker and treatment research assessing for sex differences is lacking. Women provide the majority of caregiving in DLB but how this affects the caregiving experience is uncertain. Gaining a better understanding of sex differences will be instrumental in aiding future development of sex-specific strategies in DLB for early diagnosis, care, and drug development.

Citing Articles

Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology.

Simpson A, Wyman-Chick K, Daniel M J Alzheimers Dis Rep. 2025; 9:25424823241304386.

PMID: 40034524 PMC: 11864265. DOI: 10.1177/25424823241304386.


Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology.

Bayram E, Coughlin D, Koga S, Ross O, Litvan I, Dickson D Alzheimers Dement (Amst). 2025; 17(1):e70083.

PMID: 39886324 PMC: 11780110. DOI: 10.1002/dad2.70083.


Neuropsychological test performance in mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.

Wyman-Chick K, Bayram E, Gravett S, DAntonio F, Rodriguez-Porcel F, Kane J Alzheimers Dement. 2025; 21(2):e14450.

PMID: 39791487 PMC: 11848198. DOI: 10.1002/alz.14450.


Motor signs and incident dementia with Lewy bodies in older adults with mild cognitive impairment.

Liampas I, Siokas V, Stamati P, Zoupa E, Tsouris Z, Provatas A J Am Geriatr Soc. 2024; 73(1):50-62.

PMID: 39499046 PMC: 11734088. DOI: 10.1111/jgs.19238.


Inflammation and heterogeneity in synucleinopathies.

Freuchet A, Pincon A, Sette A, Arlehamn C Front Immunol. 2024; 15:1432342.

PMID: 39281666 PMC: 11392857. DOI: 10.3389/fimmu.2024.1432342.


References
1.
Gratwicke J, Zrinzo L, Kahan J, Peters A, Brechany U, McNichol A . Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial. Brain Stimul. 2020; 13(4):1031-1039. DOI: 10.1016/j.brs.2020.04.010. View

2.
McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

3.
Ullah M, Ahmad A, Bhat S, Abu-Duhier F, Barreto G, Ashraf G . Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders. Neurosci Biobehav Rev. 2019; 102:95-105. DOI: 10.1016/j.neubiorev.2019.04.003. View

4.
Boeve B, Silber M, Ferman T, Lin S, Benarroch E, Schmeichel A . Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013; 14(8):754-62. PMC: 3745815. DOI: 10.1016/j.sleep.2012.10.015. View

5.
Liu B, Dluzen D . Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Clin Exp Pharmacol Physiol. 2007; 34(7):555-65. DOI: 10.1111/j.1440-1681.2007.04616.x. View